Literature DB >> 2000374

ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae.

C Parsot1, E Taxman, J J Mekalanos.   

Abstract

The genes encoding three lipoproteins of Vibrio cholerae were identified by a combination of DNA sequence analysis and [3H]palmitate labeling of hybrid proteins encoded by TnphoA gene fusions. The expression of these three lipoproteins, TagA, AcfD, and TcpC, was controlled by ToxR, the cholera toxin transcriptional activator. The involvement of other bacterial lipoproteins in conferring resistance to the bactericidal effects of complement prompted us to examine this possibility in V. cholerae. Remarkably, mutations in toxR and tcp genes (including tcpC), involved in the biogenesis of the toxin coregulated pili, rendered V. cholerae about 10(4)-10(6) times more sensitive to the vibriocidal activity of antibody and complement. Since V. cholerae is a noninvasive organism and toxR and tcp mutants are highly defective in intestinal colonization in animals and humans, these results raise the possibility that resistance to a gut-associated, "complement-like" bactericidal activity may be a major virulence determinant of V. cholerae and other enterobacterial species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000374      PMCID: PMC51080          DOI: 10.1073/pnas.88.5.1641

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  PapD, a periplasmic transport protein in P-pilus biogenesis.

Authors:  F Lindberg; J M Tennent; S J Hultgren; B Lund; S Normark
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

Review 2.  Complement evasion by bacteria and parasites.

Authors:  K A Joiner
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

3.  The role of the traT gene of the Salmonella typhimurium virulence plasmid for serum resistance and growth within liver macrophages.

Authors:  M Rhen; S Sukupolvi
Journal:  Microb Pathog       Date:  1988-10       Impact factor: 3.738

4.  In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae.

Authors:  V S Baselski; R A Medina; C D Parker
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Biogenesis of lipoproteins in bacteria.

Authors:  H C Wu; M Tokunaga
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

7.  Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94.

Authors:  M M Binns; J Mayden; R P Levine
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Cloning and DNA sequence of plasmid determinant iss, coding for increased serum survival and surface exclusion, which has homology with lambda DNA.

Authors:  P J Chuba; M A Leon; A Banerjee; S Palchaudhuri
Journal:  Mol Gen Genet       Date:  1989-04

9.  Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA.

Authors:  A Tagliabue; L Nencioni; L Villa; D F Keren; G H Lowell; D Boraschi
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

10.  Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter.

Authors:  V L Miller; V J DiRita; J J Mekalanos
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

View more
  33 in total

1.  Virulence and the environment: a novel role for Vibrio cholerae toxin-coregulated pili in biofilm formation on chitin.

Authors:  Gemma Reguera; Roberto Kolter
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

2.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Structural analysis of the acfA and acfD genes of Vibrio cholerae: effects of DNA topology and transcriptional activators on expression.

Authors:  C Parsot; J J Mekalanos
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

4.  Vibrio cholerae ToxT independently activates the divergently transcribed aldA and tagA genes.

Authors:  Jeffrey H Withey; Victor J Dirita
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  MxiJ, a lipoprotein involved in secretion of Shigella Ipa invasins, is homologous to YscJ, a secretion factor of the Yersinia Yop proteins.

Authors:  A Allaoui; P J Sansonetti; C Parsot
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

6.  Characterization of an avirulent pleiotropic mutant of the insect pathogen Bacillus thuringiensis: reduced expression of flagellin and phospholipases.

Authors:  M Y Zhang; A Lövgren; M G Low; R Landén
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 7.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

8.  Expression of the Vibrio cholerae gene encoding aldehyde dehydrogenase is under control of ToxR, the cholera toxin transcriptional activator.

Authors:  C Parsot; J J Mekalanos
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

9.  RNA arbitrarily primed PCR survey of genes regulated by ToxR in the deep-sea bacterium Photobacterium profundum strain SS9.

Authors:  K A Bidle; D H Bartlett
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

10.  Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.

Authors:  Roy R Chaudhuri; Mohammed Sebaihia; Jon L Hobman; Mark A Webber; Denisse L Leyton; Martin D Goldberg; Adam F Cunningham; Anthony Scott-Tucker; Paul R Ferguson; Christopher M Thomas; Gad Frankel; Christoph M Tang; Edward G Dudley; Ian S Roberts; David A Rasko; Mark J Pallen; Julian Parkhill; James P Nataro; Nicholas R Thomson; Ian R Henderson
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.